In some states with regulations that restrict other cannabis form factors, Vape holds an even more dominant share of total dollar sales.
While vape sales slowed slightly during the early months of the pandemic, the category is once again seeing strong performance, making up ~25% of total dollar sales across BDSA-tracked markets (AZ, CA, CO, FL, IL, MA, MD, MI, MO, NV, OR, PA) in Q4 2021. However, BDSA-tracked legal cannabis vape sales rebounded after this low point in November 2019 as news spread that EVALI was linked to Vitamin E acetate additives in illicit vapes. This drop signaled trouble for this fast-growing segment of the industry. As concern grew over the E-cigarette and Vaping Associated Lung Injury crisis in the fall/summer of 2019, monthly vape dollar sales across BDSA-tracked markets dropped over 10% between August 2019 and November 2019. After experiencing major disruptions being the subject of the first public health crisis in the cannabis industry, vape has solidified its place as a top cannabis product category.
0 kommentar(er)
